February 9, 2023
Payers
  • The Department of Justice (DOJ) announced that it collected $2.2 billion in False Claims Act settlements and judgments for the federal fiscal year 2022, with over $1.7 billion related to the health care industry. The $1.7 billion in collections range from fraud in Medicaid, Medicare Advantage (MA) overpayments, unlawful kickbacks, and substandard care. The largest settlement came from drugmaker Biogen, which paid $843.8 million to resolve allegations that it offered kickbacks to physicians in the form of speaker training and consulting fees, meals, and honoraria in connection with its multiple sclerosis products Avonex, Tysabri, and Tecfidera. (Press release here)